Ge Healthcare Technologies Inc. | Large-cap | Healthcare

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 19.7B
Gross Profit 8.2B 41.71%
Operating Income 2.6B 13.34%
Net Income 2.0B 10.42%
EPS (Diluted) $4.34

Balance Sheet Metrics

Total Assets 33.1B
Total Liabilities 24.4B
Shareholders Equity 8.7B
Debt to Equity 2.82

Cash Flow Metrics

Operating Cash Flow 3.2B
Free Cash Flow 1.6B

Revenue & Profitability Trend

Ge Healthcare Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 19.7B 19.6B 18.3B 17.6B 17.2B
Cost of Goods Sold 11.5B 11.6B 11.2B 10.4B 10.4B
Gross Profit 8.2B 7.9B 7.2B 7.2B 6.8B
Operating Expenses 5.6B 5.5B 4.7B 4.4B 4.0B
Operating Income 2.6B 2.4B 2.5B 2.8B 2.7B
Pre-tax Income 2.6B 2.4B 2.5B 2.9B 2.7B
Income Tax 531.0M 743.0M 563.0M 600.0M 652.0M
Net Income 2.0B 1.6B 2.0B 2.3B 13.9B
EPS (Diluted) $4.34 $3.03 $4.63 $4.94 $30.45

Income Statement Trend

Ge Healthcare Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 9.9B 9.4B 8.3B 7.0B 5.9B
Non-Current Assets 23.2B 23.0B 19.2B 19.3B 18.3B
Total Assets 33.1B 32.5B 27.5B 26.3B 24.2B
Liabilities
Current Liabilities 9.6B 9.0B 7.2B 6.8B 6.5B
Non-Current Liabilities 14.9B 16.2B 10.8B 2.7B 3.0B
Total Liabilities 24.4B 25.1B 17.9B 9.4B 9.5B
Equity
Total Shareholders Equity 8.7B 7.3B 9.6B 16.9B 14.8B

Balance Sheet Composition

Ge Healthcare Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 2.0B 1.6B 1.9B 2.3B 2.1B
Operating Cash Flow 3.2B 3.3B 3.0B 2.2B 2.7B
Investing Activities
Capital Expenditures -401.0M -386.0M -306.0M -233.0M -221.0M
Investing Cash Flow -914.0M -558.0M -398.0M -1.8B -301.0M
Financing Activities
Dividends Paid -55.0M -41.0M 0 0 -
Financing Cash Flow -606.0M -478.0M -822.0M -263.0M -2.2B
Free Cash Flow 1.6B 1.7B 1.8B 1.4B 1.4B

Cash Flow Trend

Ge Healthcare Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 14.95
Forward P/E 15.24
Price to Book 3.55
Price to Sales 1.65
PEG Ratio 15.24

Profitability Ratios

Profit Margin 11.03%
Operating Margin 14.78%
Return on Equity 26.44%
Return on Assets 5.87%

Financial Health

Current Ratio 0.98
Debt to Equity 97.52
Beta 1.29

Per Share Data

EPS (TTM) $4.76
Book Value per Share $20.07
Revenue per Share $43.40

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
gehc 32.6B 14.95 3.55 26.44% 11.03% 97.52
Veeva Systems 46.0B 59.92 7.39 14.06% 27.34% 1.24
Tempus AI 11.4B -10.55 34.99 -1,324.71% -88.27% 262.96
Doximity 10.9B 52.23 10.12 22.50% 39.13% 1.15
HealthEquity 8.8B 73.94 4.14 5.77% 9.80% 52.11

Financial data is updated regularly. All figures are in the company's reporting currency.